This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Delaware judge won’t block Metsera from terminating Pfizer deal, accepting Novo offer

By Wesley Brown ( November 5, 2025, 22:14 GMT | Insight) -- Metsera will be allowed to terminate its deal with Pfizer and accept a rival bid from Novo Nordisk, a judge with the Delaware Court of Chancery ruled. Pfizer had sought a temporary restraining order against Metsera terminating their agreement. Vice Chancellor Morgan Zurn judge said that Pfizer did not make a “requisite showing” that Metsera board members opted to accept Novo’s bid in bad faith or against the advice of requisite advisors.Metsera will be allowed to terminate its deal with Pfizer and accept a rival bid from Novo Nordisk, a judge with the Delaware Court of Chancery ruled....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login